
MDT · NYSE
Medtronic plc
$95.25 -1.33 (-1.38%)
Company overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; as well as percutaneous coronary intervention and percutaneous angioplasty balloon products.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NYSE
- Market cap
- $122B
- Employees
- 95,000
- Headquarters
- Galway
- Website
- medtronic.com
- CEO
- Geoffrey Straub Martha
- Listed
- May 2, 1973
- P/E
- 26.53
- Dividend yield
- 3.23%
Company financials
- Revenue
- $35.5B
- Gross profit
- $22B
- Operating income
- $6.3B
- EBITDA
- $9.4B
- Net income
- $4.6B
- EPS
- $3.59
- Total assets
- $91.5B
- Total debt
- $28.1B
- Gross margin
- 61.95%
- Net margin
- 13.00%
- Earnings yield
- 3.77%
Showing FY 2026